New research found that individuals with anorexia nervosa have elevated opioid neurotransmitter activity, which may contribute to appetite loss and emotional symptoms. A study from the Turku PET Centr ...

Discover how changes in opioid neurotransmitters in the brain may influence anorexia nervosa, affecting appetite, anxiety, ...

NLS Pharmaceutics Ltd. (NASDAQ: NLSP) (NASDAQ: NLSPW) ("NLS" or the "Company"), a Swiss clinical-stage biopharmaceutical company dedicated to developing therapies for rare and complex central nervous ...

A study showed that changes in the functioning of opioid neurotransmitters in the brain may underlie anorexia.

Elevated opioid neurotransmission in the brain may underlie appetite loss and emotional symptoms in anorexia nervosa.

A study conducted at Turku PET Center in Finland showed that changes in the functioning of opioid neurotransmitters in the ...

A study conducted at Turku PET Centre in Finland showed that changes in the functioning of opioid neurotransmitters in the brain may underlie anorexia.

Are dropping fentanyl-related death rates concealing other issues in the fight against this brutal form of addiction?

A major new study has revealed a long list of benefits and some little-known risks of Ozempic and other GLP-1 medications.

Naloxone is a commonly administered drug used to reverse the effects of an opioid overdose. It works by binding to opioid ...

Tris Pharma has pointed to a phase 3 win for its pain relief drug as demonstrating the candidate’s potential to help resolve the opioid crisis. | Tris Pharma has pointed to a phase 3 win for its pain ...

Learn how quickly you can expect relief from Klonopin, a benzodiazepine medication commonly prescribed for anxiety and ...